<ORIGINAL ARTICLE>Characterization of a new coagulant enzyme isolated from Trimeresurus okinavensis (Himehabu snake) venom

A potent, proteinaceous inducer of coagulation factors, has been purified to homogeneity from Trimeresurus okinavensis (Himehabu snake) by ion exchange chromatography and molecular sieving. It has an apparent molecular weight of 28,000 and it specifically converts fibrinogen to fibrin through an enzymatic reaction. This activity was confirmed by a method using synthetic substrate S-2238, though the fraction from a DEAE sephacel column chromatography shows amidolytic activity of S-2251 and S-2366, which are commonly used to measure plasmin and activated protein C activity, respectively, as well as S-2238. This thrombin-like activity of the final product was not affect by the addition of heparin and AT-III. This enzyme also aggregates normal platelets. It is considered that this purified enzyme would be useful as a hemostatic agent or research reagent

Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy

Occurrence of hypoglycemia in diabetes patients is very rare. We report here a case of frequent hypoglycemic attacks caused by inappropriate endogenous hyperinsulinemia in a female patient with poorly controlled diabetes and protein-losing gastroenteropathy. The blood glucose profiles of the patient were unstable. Results of the fasting test performed to investigate the cause of hypoglycemia suggested endogenous hyperinsulinism. Repeated selective arterial calcium injection tests suggested that hyperinsulinemia might be extrapancreatic in origin. However, efforts to detect a responsible lesion such as insulinoma were unsuccessful. Octreotide was used for the treatment of hypoglycemia and protein-losing gastroenteropathy. After treatment, although her leg edema caused by hypoalbuminemia persisted, hypoglycemia almost disappeared

Significance of fully automated tests for the diagnosis of antiphospholipid syndrome

AbstractAntiphospholipid antibodies (aPLs) can vary both immunologically and functionally, thus it is important to effectively and correctly identify their presence when diagnosing antiphospholipid syndrome. Furthermore, since many immunological/functional tests are necessary to measure aPLs, complete examinations are often not performed in many cases due to significant burden on the testing departments. To address this issue, we measured aPLs defined according to the classification criteria (anticardiolipin antibody: aCL) IgG/IgM and anti-β2 glycoprotein I antibody (aβ2GPI) (IgG/IgM) as well as non-criteria antibodies (aCL IgA, aβ2GPI IgA and aβ2GPI domain I), in a cohort of 211 patients (61 APS, 140 disease controls and 10 healthy individuals). APLs were measured using a fully automated chemiluminescent immunoassay instrument (BIO-FLASH®/ACL AcuStar®) and with conventional ELISA tests. We demonstrated that both sensitivity and accuracy of diagnosis of aCL IgG and aβ2GPI IgG were high, in agreement with the past reports. When multiple aPLs were examined, the accuracy of diagnosis increased. The proportion of APS patients that were positive for 2 or more types of aPLs (47/61, 77%) was higher than that of patients with systemic lupus erythematosus (SLE)(3/37, 9%), those with non-SLE connective tissues diseases (1/53,2%), those with other diseases or healthy volunteers. Based on these findings, it was concluded that the fully automated chemiluminescent immunoassay instrument, which allows the simultaneous evaluation of many types of aPLs, offers clear advantages for a more complete, more rapid and less labor-intensive alternative to running multiple ELISA and could help in better diagnosis for suspected APS patients

International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser-reagent test systems. Part 1: Instrument-specific issues and commonly used coagulation screening tests

Before a new method is used for clinical testing, it is essential that it is evaluated for suitability for its intended purpose. This document gives guidance for the performance of verification, validation and implementation processes required by regulatory and accreditation bodies. It covers the planning and execution of an evaluation of the commonly performed screening tests (prothrombin time, activated partial thromboplastin time, thrombin time and fibrinogen assay), and instrument-specific issues. Advice on selecting an appropriate haemostasis analyser, planning the evaluation, and assessing the reference, interval, precision, accuracy, and comparability of a haemostasis test system are also given. A second companion document will cover specialist haemostasis testing. © 2020 John Wiley & Sons Lt

Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy

Occurrence of hypoglycemia in diabetes patients is very rare. We report here a case of frequent hypoglycemic attacks caused by inappropriate endogenous hyperinsulinemia in a female patient with poorly controlled diabetes and protein-losing gastroenteropathy. The blood glucose profiles of the patient were unstable. Results of the fasting test performed to investigate the cause of hypoglycemia suggested endogenous hyperinsulinism. Repeated selective arterial calcium injection tests suggested that hyperinsulinemia might be extrapancreatic in origin. However, efforts to detect a responsible lesion such as insulinoma were unsuccessful. Octreotide was used for the treatment of hypoglycemia and protein-losing gastroenteropathy. After treatment, although her leg edema caused by hypoalbuminemia persisted, hypoglycemia almost disappeared

揚げ油の劣化(自然科学編)

1.サラダ油を用いて揚げ物を行なった結果,1回の揚げ過程によるPOVの増加は2～4であった。2.揚げ物に使用したサラダ油を調理室冷暗所に貯蔵したときのPOVの増加は容器や季節の影響をうけるが,1ケ月以内の貯蔵においては,いずれも20以下であった。3.揚げ物に2回使用したのち,1ケ月間貯蔵した油を用いて3回連続の揚げ試験を行なった結果,POVは15以下であったが,異臭を放つものがみられた。また,揚げ物を行なうことによって揚げ油のPOVが逆に減少するものもあった

Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant

In patients with autoimmune coagulation factor deficiency (AiCFD), the production of autoantibodies that inhibit coagulation factors in the blood reduces the activity of those relevant coagulation factors, resulting in severe bleeding symptoms. Recently, reports of patients with AiCFD have noted the concomitant detection of lupus anticoagulant (LA), a risk factor for thrombosis. LA-positive patients may show bleeding symptoms due to decreased activity of coagulation factor II (FII) caused by autoantibodies against FII, in addition to thrombotic symptoms, a condition termed LA-hypoprothrombinemia syndrome (LAHPS). Anti-FII antibodies in LAHPS cases are frequently cleared antibodies that can be detected using immunological techniques, such as enzyme-linked immunosorbent assay (ELISA). Recently, several cases of coagulation FV inhibitors, known as autoimmune FV deficiency, have been reported. Some of these cases may be complicated by LA, which can cause thrombosis. False-positive results for anticoagulant inhibitors are known to occur in LA cases; therefore, immunological confirmation of antibodies against coagulation factors is recommended. Additionally, acquired hemophilia A (AHA), caused by autoantibodies against FVIII, is a typical acquired hemorrhagic diathesis, although affected patients may present with thrombosis associated with LA. Thus, it is important to remember that hemorrhagic diathesis due to autoantibodies against clotting factors can also result in thrombosis, as demonstrated by the co-detection of LA. When clotting factor inhibitors are detected in LA-positive individuals, it is important to confirm the presence of autoantibodies against coagulation factors using immunological methods, such as ELISA, to avoid false-positive results

当地方における揚げ油の使用状況(自然科学編)

家庭における揚げ油使用状況を知るため,本校家政学科1年生の家庭についてアンケートを行った。結果は図1～15に示すとおりである

三重県における地域別食生活実態の公衆栄養学的考察 : 第6報 三重県松阪保健所管轄内の在宅脳卒中後遺症者の栄養摂取状態について

A survey on ADL and nutritional conditions was carried out on the patients at home with sequelae of cerebral apoplexy who were notified by medical institutions in Matsuzaka city and Meiwa-cho within the jurisdiction of the Matsuzaka Public Health Center and were discharged about three months before and the following results were obtained. (1) Of 10 patients, 3 required help, but other 7 did not require it in spite of physical handicaps such as unilateral paralysis. This might reflect the result of home care after discharge such as rehabilitation which was carried out through the medical communication system under the direction of the public health center. (2) When intake of each nutrient was compared with the standard intake in each patient, calories and protein were deficient in 6 of 10 patients and fat and vitamin B_1 and B_2 in 8 of 10 patients. Calcium and vitamin A were markedly deficient in almost all patients. (3) Intake of salt was more than 6 g in all the patients. (4) When food intake was examined by food groups, significant difference was noted between intake by each patient and the standard intake in the potato, fat, milk, green and yellow vegetables and fruits. It should be noted that 6 of 10 patients did not ingest milk at all. (5) Following these results, nutritional rehabilitation can be considered necessary for patients at home with sequelae of cerebral apoplexy